SCHEMBL13488182

SCHEMBL13488182

CC1(C)c2ccccc2-c2ccc(-c3ccc4c(-c5nc6ccccc6n5-c5ccccc5)c5ccccc5c(-c5ccc6c(c5)C(C)(C)c5ccccc5-6)c4c3)cc21

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RECQL P46063 1/20 0.39
PTGER4 P35408 1/20 0.39
HTT P42858 2/20 0.38
MAPK1 P28482 2/20 0.38
ESR1 P03372 3/20 0.37
ESR2 Q92731 3/20 0.37
ATR Q13535 1/20 0.35
PRKACA P17612 1/20 0.34
RPS6KB1 P23443 1/20 0.34
GSK3B P49841 1/20 0.34
ROCK1 Q13464 1/20 0.34
GRIA1 P42261 1/20 0.34
CACNG8 Q8WXS5 1/20 0.34
CACNG2 Q9Y698 1/20 0.34
GSR P00390 1/20 0.34
SIRT2 Q8IXJ6 1/20 0.33
SIRT1 Q96EB6 1/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC8 Q9BY41 1/20 0.33
HDAC6 Q9UBN7 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13487936 0.98 RECQL (0.38) RECQLPTGER4HTTMAPK1ESR1
SCHEMBL13487787 0.97 RECQL (0.38) RECQLPTGER4HTTMAPK1ESR1
SCHEMBL26344965 0.96 RECQL (0.42) RECQLPTGER4HTTMAPK1ESR1
SCHEMBL13488100 0.95 MAPK10 (0.37) RECQLPTGER4HTTMAPK1ESR1
SCHEMBL13488112 0.95 ESR1 (0.41) RECQLPTGER4HTTMAPK1ESR1
SCHEMBL18925699 0.95 ESR1 (0.41) RECQLPTGER4HTTMAPK1ESR1
SCHEMBL13487845 0.94 RECQL (0.38) RECQLPTGER4HTTMAPK1ESR1
SCHEMBL12247137 0.94 RECQL (0.39) RECQLPTGER4HTTMAPK1ESR1
SCHEMBL13651081 0.94 FLT3 (0.38) RECQLPTGER4HTTMAPK1ESR1
SCHEMBL13487890 0.93 ESR1 (0.42) RECQLPTGER4HTTMAPK1ESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100045170-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-25 US disclosed
US-20100045170-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100045170-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same OCIAD1, OCIAD2, ORMDL3 RECQL 3661/4885PTGER4 2083/4885HTT 3379/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.